Abstract
2′-Deoxycytidine-3N-cyanoborane (dC-BH2CN) had been found to possess cytotoxic, hypo-lipidaemic, and anti-inflammatory activity; its disposition in mice was investigated in this report. The half-life of dC-BH2CN was found to be 0.3 hours and 2′-deoxycytidine was identified as one metabolite. A second elimination rate-limited metabolite was also formed, but was not identified. dC-BH2CN was taken up in vitro in human BG-9 fibroblasts, rat red blood cells, and murine Tmolt3 cells, and in vivo in Ehrlich ascites carcinoma cells. In the Ehrlich ascites tumour, concentrations of dC-BH2CN were 4- to 8-fold higher than liver and plasma from 2 to 24 hours after administration.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
